Adebrelimab Combined With AG Regimen in Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer

NCT06916975 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

46

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer Non-resectable
Pancreatic Cancer Metastatic

Interventions

DRUG: Adebrelimab
DRUG: AG

Sponsor

Jin Xu